Skip to main content
. 2024 Feb 27;16(2):318–330. doi: 10.4240/wjgs.v16.i2.318

Table 1.

Comparison of perioperative characteristics of included patients between the two groups by propensity score matching analysis

Variables
Unmatched
P value
Matched
P value
PSE group, n = 40
Non-PSE group, n = 281
PSE group, n = 23
Non-PSE group, n = 23
Age in yr 33.95 ± 12.21 35.07 ± 14.74 0.65 33.57 ± 13.56 34.04 ± 12.23 0.90
Sex, n (%) 0.12 0.57
Male 17 156 12 10
Female 23 125 11 13
Etiology of cirrhosis, n (%) 0.88 0.30
HLD cirrhosis 34 222 19 17
HBV cirrhosis 4 48 3 4
HCV cirrhosis 1 3 1 1
Schistosomiasis cirrhosis 0 1 0 0
Alcoholic cirrhosis 0 2 0 0
Autoimmunity cirrhosis 1 3 0 1
Unknown 0 1
The size of spleen in mm
Length of spleen 161.85 ± 21.26 171.21 ± 26.74 0.04 170.13 ± 15.64 163.00 ± 25.33 0.26
Thickness of spleen 66.45 ± 11.03 73.06 ± 16.91 0.02 69.74 ± 8.77 64.43 ± 15.88 0.17
The diameter of portal vein system in cm
Portal vein 1.35 ± 0.16 1.41 ± 0.24 0.15 1.38 ± 0.19 1.28 ± 0.17 0.50
Splenic vein 1.24 ± 0.21 1.23 ± 0.24 0.71 1.23 ± 0.23 1.13 ± 0.17 0.10
Preoperative blood examination
WBC as 109/L 2.69 ± 1.05 3.13 ± 2.08 0.19 2.51 ± 1.09 3.12 ± 2.44 0.28
RBC as 1012/L 3.76 ± 0.37 3.91 ± 0.65 0.16 3.77 ± 0.43 3.58 ± 0.54 0.18
HGB in g/L 106.40 ± 18.31 109.75 ± 18.71 0.29 103.61 ± 16.80 104.96 ± 15.08 0.75
PLT as 109/L 66.35 ± 30.04 50.03 ± 28.68 0 59.26 ± 29.86 59.04 ± 48.48 0.99
TBIL in μmol/L 34.54 ± 25.58 22.98 ± 15.61 0 30.09 ± 26.63 28.14 ± 22.13 0.79
ALT in U/L 30.20 ± 13.31 29.01 ± 17.01 0.67 28.74 ± 13.03 28.96 ± 21.20 0.97
AST in U/L 38.00 ± 16.13 30.00 ± 11.44 0 33.57 ± 11.18 35.48 ± 17.46 0.66
ALB in g/L 35.04 ± 3.42 37.60 ± 4.60 0 34.77 ± 3.07 34.98 ± 3.98 0.84
PT in s 14.95 ± 3.44 14.70 ± 2.43 0.57 15.08 ± 3.49 14.30 ± 2.26 0.37
D-dimer in mg/L 1.46 ± 4.28 0.67 ± 0.83 0.01 0.47 ± 0.26 0.56 ± 0.54 0.47
Operation, n (%)
Splenectomy only 18 237 0 11 11 1
Concomitant pericardial devascularization 22 44 12 12
Intraoperative outcomes
Intraoperative blood loss in mL 399.50 ± 240.76 267.36 ± 161.07 0 450.00 ± 268.40 250.13 ± 129.02 0
Operation time in min 202.98 ± 36.38 181.64 ± 36.57 0.01 220.09 ± 35.41 189.78 ± 37.42 0.01
Postoperative complications, n (%)
PVT 14 107 0.71 8 6 0.53
PPF 6 27 0.30 4 4 1
Abdominal hemorrhage 3 6 0.06 2 3 0.65
Hospital stay in d 17.10 ± 4.42 13.99 ± 3.57 0 16.70 ± 4.18 13.52 ± 2.25 0

ALB: Albumin; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; HBV: Hepatitis B virus; HCV: Hepatitis C virus; HGB: Hemoglobin; HLD: Hepatolenticular degeneration; PLT: Platelet; PPF: Postoperative pancreatic fistula; PSE: Partial splenic embolization; PSM: Propensity score matching; PT: Prothrombin time; PVT: Portal vein thrombosis; RBC: Red blood cell; TBIL: Total bilirubin; WBC: White blood cell.